Skip to main content
. 2023 Apr 12;13:1147903. doi: 10.3389/fonc.2023.1147903

Figure 2.

Figure 2

(A) Progression-free survival by subgroup in the full analysis set. TMN, tumor, node, metastasis; PD-L1, programmed death-ligand 1; HR, hazard ratios; CI, confidence interval; (B) Overall survival by subgroup in the full analysis set. TMN, tumor, node, metastasis; PD-L1, programmed death-ligand 1; HR, hazard ratios; CI, confidence interval.*Data not presented for subgroups of “Yes in Combination of radiotherapy” owing to very few patients which precludes any meaningful analysis.